Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-11 Acetate PET-MRI in Primary Mitral Regurgitation
NCT04795856Phase 1Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2027
- Primary completion
- Aug 2028
01
Overview
Phase 1, open-label trial (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Correlation of PET metabolic findings with CMR T1/T2 parametric mapping. Planned start Jun 2027; status: withdrawn.
Beyond the preview
Go deeper on NCT04795856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04795856.